Vitamin D and tuberculosis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 51, 2012, Pages

  Grey, Andrew ^a   Bolland, Mark ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL;

ANTIMICROBIAL THERAPY; BACTERIUM CULTURE; CLINICAL PROTOCOL; HUMAN; LETTER; LUNG TUBERCULOSIS; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPUTUM CULTURE; VITAMIN SUPPLEMENTATION;

FEMALE; HUMANS; MALE; TUBERCULOSIS; VITAMIN D;

EID: 84871390188     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1216417109     Document Type: Letter

References (5)

1. Coussens AK, et al. (2012) Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci USA 109(38):15449-15454.
2. Martineau AR, et al. (2011) High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 377(9761):242-250.
3. Wejse C, et al. (2009) Vitamin D as supplementary treatment for tuberculosis: A doubleblind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 179(9):843-850.
4. Yusuf S, Wittes J, Probstfield J, Tyroler HA (1991) Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA 266(1):93-98.
5. Freemantle N (2001) Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic? BMJ 322(7292):989-991.